chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ERYTHEMA AND SWELLING OF THE LEFT DELTOID FOR 24 HOURS. FROM. NO ABSCESS. NO ANALGESIC GIVEN AT HOME. 160 MG ACETAMINOPHEN GIVEN PO IN OFFICE.INSTRUCTIONS TO RETURN IF SYMPTOMS WORSEN.
fever, lethargy, severe rash on face and body, itching, facial twitching, seizure like activity, agitation
This spontaneous report as received from a physician refers to a 32 year old male patient. Pertinent medical history was unknown. On 08-JAN-2015 the patient was vaccinated with first dose of RECOMBIVAX HB 10/1.0 microgram/ml (1 ml, once, intramuscular) due to occupation (courier). Concomitant medications were unspecified by reporter. On 08-JAN-2015, the patient experienced nausea, stomach pain, fever and was salivating. The patient medicated himself with PEPTO BISMOL. The outcome of nausea, stomach pain, fever and salivation was reported as recovered/resolved within 3 weeks after first vaccination. On 10-FEB-2015, the patient received second dose of RECOMBIVAX HB 10/1.0 microgram/ml (1 ml, once, intramuscular, lot# K014190, expiry date: 24-OCT-2016) and experienced severe nausea, which was not constant but came in waves and lasted for 5 hours. The reporter explained that the symptoms came more quickly but did not last as long as first vaccination. The patient again medicated himself with PEPTO BISMOL. The reporter stated that 4 days after second vaccination the patient was feeling fine. The patient did not seek any care. The causal relationship between the events and RECOMBIVAX HB was unknown. No further information was provided. Additional information has been requested.
Patient developed a hard lump under skin where the flu vaccine was injected. The lump is becoming smaller over time.
Pharmacist reports the patient only received the first dose of the Shingrix series; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose of Shingrix in October 2020).   On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Pharmacist reports the patient only received the first dose of the Shingrix series). The outcome of the incomplete course of vaccination was unknown.   Additional Information: Receipt Date: 15-AUG-2023 The pharmacist stated that in October 2020 patient received the only first dose of Shingrix series. Exact date, lot number or expiration date was not provided. Till the time of reporting patient did not received 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
I showed up to this clinic to receive my second dose of Moderna and I was accidentally given Pfizer instead. So I've had one dose of each. I haven't had an adverse reaction yet but I was told to report this to you.
As I was administering vaccine, during the push, the patient abruptly pulled her body away.  Some vaccine leaked out onto her arm.  I pushed some into her left arm, but the rest leaked out.  The patient had advised me up front that she had a phobia of needles.  She sat still for the initial injection, but as I pushed the vaccine she pulled away sharply.  I advised her that she seemed to only have received about half of the vaccine before she moved and that she should follow up with her primary physician and to continue to protect herself and wear her mask until advised by md.
This spontaneous report as received from a pharmacist refers to a 64 year old male patient with no pertinent medical history nor drug reaction/allergies. On an unknown date in February 2015, reported as last week, the patient was vaccinated with ZOSTAVAX, subcutaneous. Dose, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. On an unknown date in February 2015, after vaccination with ZOSTAVAX the patient experienced chicken pox like rash all over his body. The pharmacist reported that the patient was seeing his primary care physician at the time of this report. The outcome of rash vesicular was reported as not recovered. No treatment was given for adverse events. No lab diagnostics studies were performed. The relatedness between the event and suspect therapy was not provided. Additional information has been requested.
Face, Neck especially around both eyes, mouth became swollen, red with rashes, flaky skin. Both extremities especially lower became swollen the next day after the 5th injection and 3 weeks after the 4th shot.
expired dose; This spontaneous report was received from a registered nurse and refers to a 19 month old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 20-JAN-2021, the patient was vaccinated withan expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), lot# reported as "S021617,", expiration date 09-JAN-2021, 1 dose (vaccination site and route were not provided). for prophylaxis.
lt leg @ site was red & swollen Friday only;screamed, cried & was fussy for approx 48hr p/inj;
Information regarding Flu Mist (2003-2004 Formula) (influenza virus vaccine. live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a healthcare professional regarding a female patient who received a dose of vaccine on an unspecified date and developed an "ulcer under nostril." Medical history: Relevant medical history is not provided. Product details: Indication for Flumist (2003-2004 Formula) was immunization. Product was administered on an unspecified date. Dose regimen was 0.5 mL 1 time per day. Concomitant therapy: Concomitant medications were not reported. Event details: The patient experienced an ulcer under the nostril (ulcer) on the day of administration in 2003. He recovered. No additional information was available at the time of this report.
Temperature:  101-103 on March 12th,  100-101 on March 13th.  100.6 March 14,  99-100 March 15. General fatigue continues  Barely could raise right arm for 2 days Muscle weakness and joint pain for 2 days Loss of appetite  It should be noted that I contracted Covid in early November 2020 and suffered flu like symptoms for 10 days.  I was not hospitalized.
Pediatric patient had vaccine (under 18 years of age); This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric patient had vaccine (under 18 years of age)) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric patient had vaccine (under 18 years of age)). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric patient had vaccine (under 18 years of age)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment information was provided.  This report refers to a case of product administered to patient of inappropriate age, for mRNA-1273, lot #: unknown,  with no associated AEs.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up received does not contain any significant information.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age, for mRNA-1273, lot #: unknown,  with no associated AEs.
There hasn't been any adverse event reported.  This is to report to VAERS that the patient was given a High Dose vaccine at the age of 59.  Upon completion of the Flu Clinic it was discovered that a High Dose flu shot was given to a patient under the age of 65.  A patient aged 59 was given the High Dose.  We tried reaching out to the patient multiple times  but kept going to a voice mailbox that was not set up. Called patient around 12:20pm 9/25/19, 12:45pm  9/25/19, 1:20pm 9/25/19 and then again at 4:35pm on 09/25/2019.  We reached out to his MD and informed them of the situation. They said they would call if any questions.
On day vax recvd pt became very achy, feverish, & sick w/severe h/a & neck ache; had bad dreams 2nd day upset stomach & low grade fever; 3rd day low grade fever & joint ache;
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 09-MAR-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml, (lot # K012424, expiration date 05-JUN-2016. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 48 hours with the lowest recorded temperature of 32 Fahrenheit degree. The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 33 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
only the adjuvant component of Shingrix was administered to a patient on that same day; only the adjuvant component of Shingrix was administered to a patient on that same day; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd December 2022, the patient received Shingrix. On 23rd December 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 23-DEC-2022 Reporters comment: The pharmacist reported that the only the adjuvant component of Shingrix was administered to a patient. The vaccine administration facility was the same as primary reporter. Health care professional was called on behalf of another health care professional so no information on the patient was available, neither information on the vaccine.  The reporter consent to follow-up. Additional Supportive information: The only the adjuvant component of Shingrix was administered to a patient, which led inappropriate preparation of medication and inappropriate dose of vaccine administered.
Pt received Pfizer 5y-11y 2023-2024 covid vaccine. No noted adverse side effects.
Extreme tiredness Vomiting/Dry heaving 3 days Nausea and loss of appetite Diarrhea 2 days Joint and muscle pain Sore throat Headache Chills Extreme body aches Persistent cough Extreme pain in arm from shot along with mild swelling Shortness of breath Body weakness Brief Chest pain Brief Leg pain Nasal congestion Ear ache
Patient scheduled in clinic for Moderna Vaccine. Vaccine vial was one dose short. Unable to administer vaccine to patient.
Patient received the Pfizer COVID-19 vaccine on 4/1/21 and 4/22/21, so was fully vaccinated when he tested positive for COVID-19 on 8/13/21.
The day after the vaccine, I started having a migraine, which lasted two weeks.  I also had a large COVID rash covering most of the top half of my arm.  8 days after the vaccine the index finger on my left hand started to go numb.  It was just a little numb at first and then became quite significant to the point where I could barely feel anything with it.  Then it turned a little white.  I called a friend who is a hand surgeon who told me to heat it.  I was in the car with my husband, so I turned on my seat heater and put my hand in between my seat and my leg.  Within an hour my finger was back to normal and I never had any further problems with it.  The whole episode with my finger lasted a few hours.  The migraine lasted 2 weeks though.
Patient became sweaty and felt dizzy. Got patient water and they remained seated. While seated patient "passed out" for a few seconds. He never had swelling of face or tongue and did not have trouble breathing.  Pharmacist and store manager remained with patient until EMS took over. EMS put patient on stretcher and took him to hospital. Local police officers also responded after 911 call was made.
taste was altered (sweet foods, not as sweet; savory food, taste bland and bitter); This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9264: expiry date: unknown) via an unspecified route of administration in the right arm, on 27Jan2021 at 14:45, at a single dose, for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. Concomitant medications included metoprolol and duloxetine hydrochloride (CYMBALTA). The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. Place where vaccine was administered was reported as "other". On 27Jan2021, about 7 hours post injection, the patient's taste was altered (sweet foods, not as sweet; savory food, taste bland and bitter). A full 24 hours after first injection, taste was still altered. The event was considered non-serious. The patient did not receive therapy for the event. Outcome of the event was not recovered. The patient has not been tested for COVID-19 since vaccination.
I had diarrhea nausea and vomiting; I was sick for approximately 4 days; I had diarrhea nausea and vomiting; I had diarrhea nausea and vomiting; Fever and major fatigue and tiredness; Fever and major fatigue and tiredness; Arm was red and painful; Arm was red and painful; patient did not receive the second dose; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (I had diarrhea nausea and vomiting), ILLNESS (I was sick for approximately 4 days), NAUSEA (I had diarrhea nausea and vomiting), VOMITING (I had diarrhea nausea and vomiting) and PYREXIA (Fever and major fatigue and tiredness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HYDROCHLOROTHIAZIDE and GLIMEPIRIDE (AMARYL) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (I had diarrhea nausea and vomiting), ILLNESS (I was sick for approximately 4 days), NAUSEA (I had diarrhea nausea and vomiting), VOMITING (I had diarrhea nausea and vomiting), PYREXIA (Fever and major fatigue and tiredness), FATIGUE (Fever and major fatigue and tiredness), VACCINATION SITE ERYTHEMA (Arm was red and painful), VACCINATION SITE PAIN (Arm was red and painful) and PRODUCT DOSE OMISSION ISSUE (patient did not receive the second dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (I had diarrhea nausea and vomiting), ILLNESS (I was sick for approximately 4 days), NAUSEA (I had diarrhea nausea and vomiting), VOMITING (I had diarrhea nausea and vomiting), PYREXIA (Fever and major fatigue and tiredness), FATIGUE (Fever and major fatigue and tiredness), VACCINATION SITE ERYTHEMA (Arm was red and painful) and VACCINATION SITE PAIN (Arm was red and painful) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (patient did not receive the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Phone call -> Per note from/by Dr. : "Patient suddenly awoke from her sleep at 2:30 am early Weds. morning with shaking chills and "cold sweats" and a sense of a heavy heartbeat.  She called 911, EMTS arrived and she recalls her vital signs registering an elevated blood pressure of 180's systolic and heart rate into the 90's.  EMT'S stayed with her awhile - she declined transport to a hosp. for further work up."
Felt lousy Thursday, Friday and Saturday. Alternated between hot and cold, broke out in red blotches on arms stomach and legs 1wk after vaccine has a "non stop" headaches and occasionally feels "hot"
Got shot at hospital . ...sat for 15/20 minutes.....left to come home..noticed dry mouth, throat. about 10 minutes later I noticed i was having a hard time swallowing..i kept trying and trying and thought I better get somewhere, was on way to hospital and I started to be able to swallow. no idea what happened but was so glad i was able to swallow..I had severe muscle pain that night of the shot and the next 3 days. . Then later on the 3rd or 4th  I noticed my bottom lip swelling, then it felt like my nose was swelling, tingly...then a hive came out on my face. I took an allergy pill and in about 30 minutes it started to subside a little...I called my Dr before I went back for the second shot and was advised not to take it.
Patient was fully vaccinated, developed COVID, and passed away on 02/17/2022. Patient is currently being investigated by the COVID mortality review team to determine if death was COVID related.
Pt recvd 1st dose Hep B 3FEB92; @ end of Feb pt devel h/a, dizziness, & nausea; On 3MAR92 had visual disturbance w/loss of vision or "blind spots"; On 4MAR92 devel maculopapular rash on abd; Next day seen by MD stated scars in back of eyes;
Mother stated child had red, warm rash on genitals that she just noticed today. Rash is not painful and doesn't itch. Advised mother to take child to the doctor for examination and treatment if needed and she agreed.
Sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication and treatment medication was included.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 43 year old white female of unspecified ethnicity. Initial information was processed along with the additional information received on 11-JAN-2022. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On 09-APR-2021, the patient received covid-19 vaccine ad26.cov2.s (dose number in series: 1) (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to left arm for prophylactic vaccination. No concomitant medications were reported. On 06-NOV-2021, the patient received booster dose of non-company suspect vaccine mrna 1273 (Moderna) (dose number in series: 2) (form of admin, route of admin not reported, batch number: 071F21A expiry: UNKNOWN) dose was not reported, administered for prophylactic vaccination. On 30-DEC-2021, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced symptoms of congestion, runny nose, and sneezing (suspected covid-19 infection) and reported her illness is a mild case. On 04-JAN-2022, the patient experienced suspected clinical vaccination failure. Laboratory data included: COVID-19 antigen test (Home kit test) (NR: not provided) Positive (dose number in series: 1). The action taken with covid-19 vaccine ad26.cov2.s, and mrna 1273 (Moderna) was not applicable. The patient had not recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition) This report was associated with product quality complaint number: 90000210214. The suspected product quality complaint has been confirmed to be the reported allegation was not confirmed and the root cause was determined to be not manufacturing related based on the PQC evaluation/investigation performed.; Sender's Comments: V0: 20220105417-covid-19 vaccine ad26.cov2.s-Suspected clinical vaccination failure . This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
numbness and tingling on my left cheek; numbness and tingling on my left cheek; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 33-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: Unknown), via an unspecified route of administration on 29May2021 at 10:15 (at the age of 33 years) as 1st single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced minor numbness and tingling on his left cheek on 29May2021. The patient received first dose of the Pfizer COVID vaccine and had a minor reaction of numbness and tingling on his left cheek, few (2-3) hours after the vaccine. It was reported that patient did not think that this should be a concern or if it was something that would happen after vaccine and enquired about the side effect, whether it was common and will it go. The outcome of the event was unknown.  Follow up attempts are completed. No further information is expected.
Approximately 6 hours following vaccine I started to experience  more extensive discomfort in areas where I had metal implants and past surgeries ie. cervical spine, femur, thorasic spine and increased pain in areas that I have athritus to the point I could not sleep.  I finally fell asleep at 6:00 am after a hot shower and woke up  at 10:00 am with reduced pain.  It appeared to affect areas of  past and present injuries.
Information has been received from a physician concerning a 21 year old female with no known allergies who on 01-FEB-2007 was vaccinated intramuscularly in the right deltoid with Gardasil (lot # not provided). The physician reported that after administering the injection she "turned around literally for a second" and when she turned back to the patient she found her "on the floor, with her rear in the air". The physician stated that she called for her assistant for help and the patient was already conscious, "she was only out for a second". The patient reported to the physician that she felt dizzy and felt like she instantly went to sleep. The physician reported that the patients blood pressure and pulse were normal (actual measurements not provided). The physician reported that the patient was observed in the office, had no additional episodes and considered to have recovered from the event and sent home. The physician stated that she did not feel the event was disabling and would continue the series of vaccination of Gardasil with the patient, but would have her reclined when administering future vaccinations. Additional information has been requested.